Matthew Mei

Also affiliated with City of Hope

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies”.

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3706

N/A

4.4DataRank · unranked

198 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2405888

N/A

3.4DataRank · unranked

211 citations

Michael LeBlanc, Sharon M. Castellino, Hongli Li, Sarah C. Rutherford, Andrew M. Evens +42 more

Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Blood(2022)10.1182/blood.2022015423

N/A

3.0DataRank · unranked

121 citations

Hun Ju Lee, Joycelynne Palmer, Robert Chen, Ni‐Chun Tsai, Lu Chen +18 more

Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial

The Lancet Haematology(2022)10.1016/s2352-3026(22)00318-0

N/A

1.4DataRank · unranked

41 citations

Lu Chen, Yago Nieto, Leona Holmberg, Patrick B. Johnston, Matthew Mei +20 more

Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study

Blood Advances(2021)10.1182/bloodadvances.2021005035

N/A

1.4DataRank · unranked

45 citations

Ni‐Chun Tsai, Timothy W. Synold, Sally Mokhtari, Weimin Tsia, Joycelynne Palmer +14 more

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Blood(2023)10.1182/blood.2023020485

N/A

1.3DataRank · unranked

40 citations

Lu Chen, James Godfrey, Joo Y. Song, Colt A. Egelston, Sandrine Puverel +18 more

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma

Blood Advances(2021)10.1182/bloodadvances.2021004981

N/A

0.733DataRank · unranked

13 citations

Joycelynne Palmer, Vikram Adhikarla, Dave Yamauchi, Erasmus Poku, James R. Bading +23 more

Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study

The Lancet Haematology(2024)10.1016/s2352-3026(24)00171-6

N/A

0.673DataRank · unranked

20 citations

Jasmine Zain, Kerry J. Savage, Tatyana Feldman, Jonathan E. Brammer, Lu Chen +14 more

Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma

Haematologica(2023)10.3324/haematol.2023.283002

N/A

0.599DataRank · unranked

19 citations

Matthew Mei, Lu Chen, Joo Y. Song, Victoria Bedell, Elizabeth Budde +13 more

Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/j.clml.2023.05.011

N/A

0.182DataRank · unranked

2 citations

Joycelynne Palmer, Nicole Tsai, Jennifer Simpson, James O’Hearn, Anthony S. Stein +10 more

Data from Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

(2023)10.1158/1078-0432.c.6531017.v1

N/A

0DataRank · unranked

0 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more

Data from Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

(2023)10.1158/1078-0432.c.6531017

N/A

0DataRank · unranked

0 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more

Coronary artery calcium and cardiovascular outcomes in patients with lymphoma undergoing autologous hematopoietic cell transplantation

Cancer(2024)10.1002/cncr.35252

N/A

0DataRank · unranked

2 citations

June‐Wha Rhee, Aleksi Iukuridze, Alysia Bosworth, Sitong Chen, Liezl Atencio +12 more

Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome‐positive acute lymphoblastic leukemia

American Journal of Hematology(2024)10.1002/ajh.27365

N/A

0DataRank · unranked

0 citations

Shanpeng Li, Jianying Zhang, Hoda Pourhassan, Vaibhav Agrawal, Dat Ngo +14 more

Trends in First-Line Use of Radiation Therapy for Early-Stage Gastric Marginal Zone Lymphoma

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.07.1471

N/A

0DataRank · unranked

0 citations

Amanda Schwer, Savita Dandapani, J.Y.C. Wong, Nayel Khan, Avyakta Kallam +11 more

Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high‐risk relapsed/refractory Hodgkin lymphoma

HemaSphere(2025)10.1002/hem3.70126

N/A

0DataRank · unranked

8 citations

Joycelynne Palmer, Hun Ju Lee, Iris Isufi, Robert Chen, Ni‐Chun Tsai +13 more

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.04.015

N/A

0DataRank · unranked

12 citations

Ni‐Chun Tsai, Sally Mokhtari, Monzr M. Al Malki, Haris Ali, Amandeep Salhotra +11 more

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis

Blood Advances(2025)10.1182/bloodadvances.2025016845

N/A

0DataRank · unranked

2 citations

Tamer Othman, Paul Frankel, Christopher Ruel, Christina Poh, Samantha Herbert +20 more

Allogeneic Hematopoietic Cell Transplantation for Relapsed and Refractory Philadelphia Negative B Cell ALL in the Era of Novel Salvage Therapies

Transplantation and Cellular Therapy(2020)10.1016/j.jtct.2020.12.020

N/A

0DataRank · unranked

10 citations

Dongyun Yang, Monzr M. Al Malki, Matthew Mei, Sally Mokhtari, Andrew Artz +17 more

Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia

American Journal of Hematology(2020)10.1002/ajh.25929

N/A

0DataRank · unranked

36 citations

Jianying Zhang, Matthew Mei, Monzr M. Al Malki, Shukaib Arslan, Dat Ngo +14 more

Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.01.029

N/A

0DataRank · unranked

25 citations

Dongyun Yang, Sally Mokhtari, Monzr M. Al Malki, Haris Ali, Karamjeet Sandhu +14 more

Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation

Cancer(2020)10.1002/cncr.32752

N/A

0DataRank · unranked

24 citations

Navneet S. Majhail, Yizeng He, Kwang Woo Ahn, Carlos Litovich, Sairah Ahmed +32 more

Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes

Blood Cancer Journal(2021)10.1038/s41408-021-00516-1

N/A

0DataRank · unranked

7 citations

Raju Pillai, Dongyun Yang, Lixin Yang, Shukaib Arslan, Sally Mokhtari +15 more

Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit

Haematologica(2022)10.3324/haematol.2021.279999

N/A

0DataRank · unranked

7 citations

Mehdi Hamadani, Kwang Woo Ahn, Yue Chen, Mohamed A. Kharfan‐Dabaja, Craig S. Sauter +2 more

Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma

American Journal of Hematology(2023)10.1002/ajh.27069

N/A

0DataRank · unranked

34 citations

Stacy Pak, Matthew Mei, Yan Wang, Leslie Popplewell, John H. Baird +13 more

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

Hematological Oncology(2023)10.1002/hon.3163_5

N/A

0DataRank · unranked

21 citations

Michael LeBlanc, Sharon M. Castellino, Huilin Li, Sarah C. Rutherford, Andrew M. Evens +41 more

Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell Therapy

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2022.7100

N/A

0DataRank · unranked

12 citations

Aleksi Iukuridze, Tianhui He, Alysia Bosworth, Lanie Lindenfeld, Jennifer Berano Teh +17 more